BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9316673)

  • 21. [Tremor-dominant form of Parkinson's disease].
    Zalyalova ZA; Katunina EA; Pokhabov DV; Munasipova SE; Ermakova MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):28-35. PubMed ID: 38676674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of Parkinson's disease. Practical criteria of treatment].
    Casacchia M; Carolei A; Zamponi A; Agnoli A; Fazio C
    Recenti Prog Med; 1976 May; 60(5):567-84. PubMed ID: 14360
    [No Abstract]   [Full Text] [Related]  

  • 23. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
    Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C
    Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tremor, the cogwheel phenomenon and clonus in Parkinson's disease.
    Findley LJ; Gresty MA; Halmagyi GM
    J Neurol Neurosurg Psychiatry; 1981 Jun; 44(6):534-46. PubMed ID: 7276968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa reduces muscle tone and lower extremity tremor in Parkinson's disease.
    Burleigh A; Horak F; Nutt J; Frank J
    Can J Neurol Sci; 1995 Nov; 22(4):280-5. PubMed ID: 8599770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action tremor and weakness in Parkinson's disease: a study of the elbow extensors.
    Brown P; Corcos DM; Rothwell JC
    Mov Disord; 1998 Jan; 13(1):56-60. PubMed ID: 9452327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
    van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
    Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?
    Peppe A; Gasbarra A; Stefani A; Chiavalon C; Pierantozzi M; Fermi E; Stanzione P; Caltagirone C; Mazzone P
    Parkinsonism Relat Disord; 2008 Aug; 14(6):501-4. PubMed ID: 18337153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blocker therapy for tremor in Parkinson's disease.
    Crosby NJ; Deane KH; Clarke CE
    Cochrane Database Syst Rev; 2003; 2003(1):CD003361. PubMed ID: 12535472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease.
    Rocchi L; Chiari L; Horak FB
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):267-74. PubMed ID: 12185157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficiency of new forms of madopar in Parkinson's disease].
    Vendrova MI; Sadekov RA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
    Prakash KM; Kek PC
    Parkinsonism Relat Disord; 2010 Dec; 16(10):691-2. PubMed ID: 20729126
    [No Abstract]   [Full Text] [Related]  

  • 33. Tremor-predominant Parkinson's disease. Approaches to treatment.
    Marjama-Lyons J; Koller W
    Drugs Aging; 2000 Apr; 16(4):273-8. PubMed ID: 10874522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson's disease.
    Yang Y; Gao F; Gao L; Miao J
    BMC Neurol; 2023 Oct; 23(1):360. PubMed ID: 37803329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
    Dirkx MF; Zach H; van Nuland A; Bloem BR; Toni I; Helmich RC
    Brain; 2019 Oct; 142(10):3144-3157. PubMed ID: 31509182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-frequency analysis of tremors.
    O'Suilleabhain PE; Matsumoto JY
    Brain; 1998 Nov; 121 ( Pt 11)():2127-34. PubMed ID: 9827772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
    Lyytinen J; Kaakkola S; Ahtila S; Tuomainen P; Teräväinen H
    Mov Disord; 1997 Jul; 12(4):497-505. PubMed ID: 9251066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tremorlytic activity of budipine in Parkinson's disease.
    Spieker S; Eisebitt R; Breit S; Przuntek H; Müller D; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1999; 22(2):115-9. PubMed ID: 10202609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of resting tremor by beta-adrenergic blockade.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Chase TN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1173-7. PubMed ID: 6148881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible Parkinson's disease revealed by a pure head resting tremor.
    Gan J; Xie-Brustolin J; Gervais-Bernard H; Vallet AE; Broussolle E; Thobois S
    J Neurol Sci; 2009 Apr; 279(1-2):121-3. PubMed ID: 19176228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.